Duke-NUS - Cancer and Stem Cell Biology

The Programme in Cancer and Stem Cell Biology (CSCB) is one of five founding Signature Research Programmes of the Duke-NUS Medical School. CSCB has a broad scope of research. Our faculty engage in hypothesis-driven basic science and disease-oriented investigation, as well as active drug discovery and innovative clinical trials. We are committed to translation of key findings, and our faculty have moved basic science discoveries from bench to bedside, with clinical trials in multiple cancers driven by discoveries made by CSCB scientists.

Our Vision

Pioneering cancer care through research and education. 

 

Cancer

Cancer is the number one killer in the world today. At the Cancer and Stem Cell Biology (CSCB) Programme, our scientists are relentless in the pursuit of the causes and treatments for cancer and related diseases.

Our Mission

Conducting world-class research and training in cancer and stem cell biology, through leveraging resources and collaborations in Duke-NUS, Singapore, Duke USA, and throughout the world. 

Director's Message

Welcome to the website of The Programme in Cancer and Stem Cell Biology (CSCB).

CSCB is one of five founding Signature Research Programmes of the Duke-NUS Medical School. Our Programme recruited its first faculty members in 2006, and we moved to the purpose-built Khoo Teck Puat (KTP) building in 2009. CSCB is an essential component of Duke-NUS. We engage in world-class research and training for scientists on both the PhD and MD/PhD tracks. 

The CSCB core faculty have research labs in KTP. The impact of CSCB is greatly enhanced by our diverse collaborative networks. We have a close relationship with researchers at the National Cancer Centre Singapore and the Department of Haematology on the Outram Campus of SingHealth. Our faculty work closely with researchers and clinicians throughout Singapore, most notably with the Cancer Science Institute at the National University Hospital and A*STaR laboratories at Biopolis. Several faculty have major ongoing projects with the Experimental Therapeutics Centre, whose mission is to develop new drugs.

CSCB has a broad scope of research. Our faculty engage in hypothesis-driven basic science and disease-oriented investigation, as well as active drug discovery and innovative clinical trials. We are committed to translation of key findings, and our faculty have moved basic science discoveries from bench to bedside, with clinical trials in gastric cancer, lung cancer and leukemia driven by discoveries made by CSCB scientists.

We welcome your interest, and we encourage you to learn more about the research and training opportunities offered by our program.

 

David M. Virshup

Professor and Director

Events

Research
04 Jul 2024
Noon Seminar: Dr. Louise Cheng - “Understanding plasticity during de-dedifferentiation”
Research
03 Jun 2024
Noon Seminar : Dr. Fan BAI - "Somatic mutagenesis in morphologically normal human tissues"
Research
09 May 2024
Noon Seminar: Dr. Kristijan Ramadan - “Chromatin-Associated Degradation (CHROMAD) in genome stability and cancer therapy”
}

News

29 Sep 2023
Advancing medical frontiers by bridging the gap between the lab and the clinic
20 Feb 2023
New study uncovers genetic risks of getting disease among different ethnicities in Singapore
17 Feb 2023
A new way to measure the length of a single telomere could provide information on how rapidly we are aging and what we need to do to slow it down.

Publications

29 Mar 2024
"The 10th International MDM2 Workshop": Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in Asia
14 Mar 2024
Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma
13 Mar 2024
A tough act to swallow: Streptococcusanginosus and gastric cancer

Browser not supported

Modern websites need modern browsers

To enjoy the full experience, please upgrade your browser

Try this browser